These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 12402577)
1. Lymphocyte subset counts in continuous ambulatory peritoneal dialysis patients in relation to administration of recombinant human erythropoietin and angiotensin-converting enzyme inhibitors. Grzegorzewska AE; Leander M Adv Perit Dial; 2002; 18():6-11. PubMed ID: 12402577 [TBL] [Abstract][Full Text] [Related]
2. Total and subset lymphocyte counts, angiotensin converting enzyme inhibitors, and dialysis duration in younger and older peritoneal dialysis patients. Leander M; Grzegorzewska AE; Karolewski M Adv Perit Dial; 2004; 20():190-3. PubMed ID: 15384824 [TBL] [Abstract][Full Text] [Related]
3. Lymphocyte subsets in the course of continuous ambulatory peritoneal dialysis. Grzegorzewska AE; Leander M Adv Perit Dial; 2001; 17():10-4. PubMed ID: 11510253 [TBL] [Abstract][Full Text] [Related]
4. Erythropoietin resistance in patients on continuous ambulatory peritoneal dialysis. Nakamoto H; Kanno Y; Okada H; Suzuki H Adv Perit Dial; 2004; 20():111-6. PubMed ID: 15384808 [TBL] [Abstract][Full Text] [Related]
5. Effects of angiotensin-converting enzyme inhibitors on anemia and erythropoietin requirements in peritoneal dialysis patients. Navarro JF; Macía ML; Mora-Fernández C; Gallego E; Chahin J; Méndez ML; del Castillo N; Rivero A; García J Adv Perit Dial; 1997; 13():257-9. PubMed ID: 9360694 [TBL] [Abstract][Full Text] [Related]
6. [The effects of ACE inhibitor treatment and ACE gene polymorphism on erythropoiesis in chronic hemodialysis patients]. Hatano M; Yoshida T; Mimuro T; Kimata N; Tsuchiya K; Sanaka T; Nihei H Nihon Jinzo Gakkai Shi; 2000 Oct; 42(8):632-9. PubMed ID: 11195399 [TBL] [Abstract][Full Text] [Related]
7. Total lymphocyte count and subpopulation lymphocyte counts in relation to dietary intake and nutritional status of peritoneal dialysis patients. Grzegorzewska AE; Leander M Adv Perit Dial; 2005; 21():35-40. PubMed ID: 16686282 [TBL] [Abstract][Full Text] [Related]
8. ACE inhibitors or angiotensin II receptor blockers in dialysed patients and erythropoietin resistance. Saudan P; Halabi G; Perneger T; Wasserfallen JB; Wauters JP; Martin PY; J Nephrol; 2006; 19(1):91-6. PubMed ID: 16523432 [TBL] [Abstract][Full Text] [Related]
9. Effects of human recombinant erythropoietin on inflammatory status in peritoneal dialysis patients. Aguilera A; Bajo MA; Díez JJ; Ruiz-Caravaca ML; Vicenta Cuesta M; Alvarez V; Codoceo R; Selgas R Adv Perit Dial; 2002; 18():200-5. PubMed ID: 12402619 [TBL] [Abstract][Full Text] [Related]
10. Total lymphocyte count and subpopulation lymphocyte count in relation to blood bicarbonate concentration in peritoneal dialysis patients. Grzegorzewska AE; Leander M Adv Perit Dial; 2005; 21():31-4. PubMed ID: 16686281 [TBL] [Abstract][Full Text] [Related]
11. [Numerical and functional alterations in T and B lymphocyte subpopulations in CAPD patients treated with recombinant human erythropoietin]. Tanabe R Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1159-68. PubMed ID: 7815748 [TBL] [Abstract][Full Text] [Related]
12. Lymphocyte subset counts in CAPD patients in relation to administration of recombinant human erythropoietin and angiotensin-converting enzyme inhibitors. Grzegorzewska AE; Leander M Perit Dial Int; 2002; 22(5):625-8. PubMed ID: 12455577 [No Abstract] [Full Text] [Related]
13. Recombinant human erythropoietin (rHuEPO) therapy has no effect on peritoneal transport in CAPD patients: a short-term study. Wong PN; Mak SK; Lo KY; Tong GM; Wong AK Adv Perit Dial; 1998; 14():11-3. PubMed ID: 10649682 [TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of immunophenotypic abnormalities in cellular immunity of uremic patients undergoing either hemodialysis or continuous ambulatory peritoneal dialysis. Griveas I; Visvardis G; Fleva A; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Ginikopoulou E; Meimaridou D; Paulitou A; Sakellariou G Ren Fail; 2005; 27(3):279-82. PubMed ID: 15957543 [TBL] [Abstract][Full Text] [Related]
15. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients. Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934 [TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone contributes to variations in blood morphology in diabetic and non diabetic patients treated with continuous ambulatory peritoneal dialysis. Grzegorzewska AE; Mariak I Adv Perit Dial; 2001; 17():5-9. PubMed ID: 11510296 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin converting enzyme inhibitors impair recombinant human erythropoietin induced erythropoiesis in patients with chronic renal failure. Qureshi IZ; Abid K; Ambreen F; Qureshi AL Saudi Med J; 2007 Feb; 28(2):193-6. PubMed ID: 17268695 [TBL] [Abstract][Full Text] [Related]
18. Effects of recombinant human erythropoietin on fibrinolytic system in children on continuous ambulatory peritoneal dialysis. Gündüz Z; Kisaarslan FA; Düsünsel R; Poyrazoglu HM; Saraymen R; Per H Adv Perit Dial; 1999; 15():278-82. PubMed ID: 10682118 [TBL] [Abstract][Full Text] [Related]
19. Plasma and peritoneal endothelin levels and blood pressure in CAPD patients with or without erythropoietin replacement therapy. Lebel M; Moreau V; Grose JH; Kingma I; Langlois S Clin Nephrol; 1998 May; 49(5):313-8. PubMed ID: 9617496 [TBL] [Abstract][Full Text] [Related]
20. Comparison of immunophenotypes in the blood of patients on continuous ambulatory peritoneal dialysis, asymptomatic and with peritonitis. Klínger J; Enríquez J; Arturo JA; Delgado M; Avila G; Mosquera M Adv Perit Dial; 2002; 18():165-9. PubMed ID: 12402612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]